No image available for this title

LITERATURE

Nebivolol: A Review of its Use in the Management of Hypertension and Chronic Heart Failure


Nebivolol is a third-generation β-adrenoceptor antagonist. It differs from other β-adrenoceptor antagonists as it combines highly selective β1-adrenoceptor antagonist properties with nitric oxide-mediated vasodilatory actions and beneficial effects on endothelial function. Nebivolol is approved in Europe and several other countries for the treatment of essential hypertension and in Europe for the treatment of stable mild or moderate chronic heart failure (CHF) in addition to standard therapies in elderly patients aged ≥70 years.


Availability

Nevodio-003Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Drugs 2006; 66 (10): 1389-1409
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous